Year
2023
-
Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases
-
NewVac Reports Primary Endpoint Met in Phase II Clinical Trial of Quisinostat in Platinum-Resistant Ovarian Cancer
-
Regen BioPharma Begins Optimization of NR2F6 Small Molecule Modulators
-
ChemDiv Announces Multi-Year Hit Identification Collaboration with Janssen
-
ChemDiv to Help Afraxis Advance Synaptic Profiling Platform for CNS Drug Discovery
-
ChemDiv Achieves Milestone in Viriom Collaboration on Elsulfavirine/VM1500A Long Acting Injectable Formulation Development
-
Nature Communications Publishes a Study that Identified Small Molecule Which Imposes Metabolic Stress and Cellular Death in Malignant Cells
-
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
-
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
-
Regen BioPharma, Inc.’s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6